1. Volume 15, Issue 8, Pages 829-840 (July 2014)
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial 
Prof Gary Middleton, MD, Paul Silcocks, BMBCh, Trevor Cox, PhD, Prof Juan Valle, MD, Jonathan Wadsley, MA, David Propper, MD, Fareeda Coxon, MBBS, Paul Ross, PhD, Srinivasan Madhusudan, PhD, Tom Roques, BMBCh, Prof David Cunningham, MD, Stephen Falk, MD, Nick Wadd, FRCP, Mark Harrison, PhD, Pippa Corrie, FRCP, Tim Iveson, MD, Angus Robinson, FRCR, Karen McAdam, FRCP, Martin Eatock, FRCP, Prof Jeff Evans, MD, Caroline Archer, MBBS, Tamas Hickish, FRCP, Angel Garcia-Alonso, MD, Marianne Nicolson, FRCP, Prof William Steward, PhD, Alan Anthoney, PhD, William Greenhalf, PhD, Victoria Shaw, PhD, Eithne Costello, PhD, Dean Naisbitt, PhD, Charlotte Rawcliffe, MSc, Gemma Nanson, BSc, Prof John Neoptolemos, MD 
The Lancet Oncology 
Volume 15, Issue 8, Pages (July 2014)
DOI: /S (14)
Copyright © 2014 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
The Lancet Oncology  , DOI: ( /S (14) )
Copyright © 2014 Elsevier Ltd Terms and Conditions

3. Figure 2
Kaplan-Meier curves of overall survival (A) and forest plot by key subgroups (B, C)
The Lancet Oncology  , DOI: ( /S (14) )
Copyright © 2014 Elsevier Ltd Terms and Conditions

4. Figure 3 Time to progression by treatment group
Time to progression was defined as time to progression or progression-related death with censoring of deaths from other causes.
The Lancet Oncology  , DOI: ( /S (14) )
Copyright © 2014 Elsevier Ltd Terms and Conditions

5. Figure 4
Overall survival according to a positive or negative delayed-type hypersensitivity response in patients assigned to chemoimmunotherapy
(A) Patients randomly assigned to sequential chemoimmunotherapy, conditional on reaching week 18. (B) Patients randomly assigned to concurrent chemoimmunotherapy, conditional on reaching week 10.
The Lancet Oncology  , DOI: ( /S (14) )
Copyright © 2014 Elsevier Ltd Terms and Conditions